| Temsirolimus studied in …STUDIED_INderived175 of 175show fewer |
|---|
| → studied in | NCT02389309Phase 1 · active not recruiting Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors · 175 trials list this drug (10 active) | — | — | Malignant Solid Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01375829Phase 1 · active not recruiting Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · 175 trials list this drug (10 active) | — | — | Endometrial Adenocarcinoma,Endometrial Serous Adenocarcinoma,Endometrial Adenosquamous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567435Phase 3 · active not recruiting Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma · 175 trials list this drug (10 active) | — | — | Rhabdomyosarcoma,Alveolar Rhabdomyosarcoma,Embryonal Rhabdomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · 175 trials list this drug (10 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02215720Phase 1 · completed Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396408Phase 2 · active not recruiting A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours · 175 trials list this drug (10 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 175 trials list this drug (10 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03203525Phase 1 · terminated Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01087554Phase 1 · active not recruiting Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00980460Phase 3 · completed Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer · 175 trials list this drug (10 active) | — | — | PRETEXT I Hepatoblastoma,PRETEXT II Hepatoblastoma,PRETEXT III Hepatoblastoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00600496Phase 1 · completed A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) · 175 trials list this drug (10 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01552434Phase 1 · terminated Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm,Mesothelial Neoplasm,Malignant Breast Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05773326early Phase 1 · terminated Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG · 175 trials list this drug (10 active) | — | — | Glioblastoma,Glioma,Malignant Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01187199Phase 1 · active not recruiting Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297606Phase 2 · recruiting Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) · 175 trials list this drug (10 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326468NA · withdrawn Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer · 175 trials list this drug (10 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420613Phase 1 · completed Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma · 175 trials list this drug (10 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529593Phase 1 · terminated Temsirolimus in Combination With Metformin in Patients With Advanced Cancers · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01210482completed Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700258completed Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] · 175 trials list this drug (10 active) | — | — | Carcinoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00838955Phase 2 · terminated Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma · 175 trials list this drug (10 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03158389Phase 1/Phase 2 · completed NCT Neuro Master Match - N²M² (NOA-20) · 175 trials list this drug (10 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01517243Phase 2 · completed Phase II Study of Alternating Sunitinib and Temsirolimus · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343718Phase 1 · completed Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours · 175 trials list this drug (10 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614197Phase 1 · completed A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma · 175 trials list this drug (10 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02238496Phase 1 · completed Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas · 175 trials list this drug (10 active) | — | — | Mixed Glioma,Anaplastic Astrocytoma,Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00593060Phase 1 · completed Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer · 175 trials list this drug (10 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01611116Phase 2 · completed Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia · 175 trials list this drug (10 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767194Phase 2 · completed Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma · 175 trials list this drug (10 active) | — | — | Ganglioneuroblastoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174199Phase 1 · terminated Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer · 175 trials list this drug (10 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112840Phase 1/Phase 2 · completed CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer · 175 trials list this drug (10 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01381692Phase 1/Phase 2 · completed Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma · 175 trials list this drug (10 active) | — | — | Non-Hodgkin Lymphoma,Small Lymphocytic Lymphoma,Follicular Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01392183Phase 2 · completed Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) · 175 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01051557Phase 1/Phase 2 · completed Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma · 175 trials list this drug (10 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827943Phase 2 · completed Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer · 175 trials list this drug (10 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01065662Phase 1 · completed AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies · 175 trials list this drug (10 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01687673Phase 2 · completed Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma · 175 trials list this drug (10 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02093598Phase 2 · completed POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus · 175 trials list this drug (10 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01596140Phase 1 · completed Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00376688Phase 2 · completed Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer · 175 trials list this drug (10 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03571438NA · unknown Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors · 175 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281917Phase 2 · completed Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma · 175 trials list this drug (10 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076543Phase 1/Phase 2 · completed Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma · 175 trials list this drug (10 active) | — | — | Non-Hodgkin Lymphoma,Adult Hodgkin Lymphoma,AIDS-Related Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083368Phase 1/Phase 2 · completed Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy · 175 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196429Phase 2 · completed Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer · 175 trials list this drug (10 active) | — | — | Malignant Ovarian Neoplasm,Ovarian Clear Cell Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00429793Phase 2 · completed Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · 175 trials list this drug (10 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00723255Phase 2 · completed Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer · 175 trials list this drug (10 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00729586Phase 2 · completed Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer · 175 trials list this drug (10 active) | — | — | Endometrial Carcinoma,Endometrial Neoplasm,Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026623Phase 1/Phase 2 · completed Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer · 175 trials list this drug (10 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01180049Phase 4 · completed Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma · 175 trials list this drug (10 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00909831Phase 1 · completed Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00761644Phase 1 · completed Doxil, Bevacizumab and Temsirolimus Trial · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · 175 trials list this drug (10 active) | — | — | Primary Peritoneal Carcinoma,Adult Liver Carcinoma,Digestive System Neuroendocrine Tumor G1+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · 175 trials list this drug (10 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Osteosarcoma,Childhood Angiosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378703Phase 2 · completed Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer · 175 trials list this drug (10 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329719Phase 1/Phase 2 · completed Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma · 175 trials list this drug (10 active) | — | — | Adult Glioblastoma,Adult Brain Neoplasm,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560012Phase 2 · terminated Personalized Targeted Inhibitors Treatment in Renal Cell Cancer · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01111825Phase 1/Phase 2 · completed Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer · 175 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00838539Phase 1 · completed Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors · 175 trials list this drug (10 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01378377Phase 1 · terminated Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus · 175 trials list this drug (10 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01019434Phase 2 · completed Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827267Phase 2 · completed Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer · 175 trials list this drug (10 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335764Phase 1/Phase 2 · completed Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · 175 trials list this drug (10 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02423954Phase 1/Phase 2 · terminated Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Pancreatic Neoplasm,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022724Phase 1/Phase 2 · completed CCI-779 in Treating Patients With Malignant Glioma · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00699491Phase 1/Phase 2 · completed Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer · 175 trials list this drug (10 active) | — | — | Breast Carcinoma,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00784914Phase 1 · completed A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01090466Phase 1/Phase 2 · completed Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium · 175 trials list this drug (10 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00782275Phase 2 · completed Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01646021Phase 3 · completed Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy · 175 trials list this drug (10 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787969Phase 1 · completed Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma · 175 trials list this drug (10 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00998036Phase 1 · completed Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors · 175 trials list this drug (10 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00610493Phase 1 · completed Bevacizumab and Temsirolimus in Patients With Advanced Malignancy · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00775593Phase 2 · completed Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia · 175 trials list this drug (10 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01182883Phase 1 · withdrawn A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors · 175 trials list this drug (10 active) | — | — | Glioma,Brain Stem Neoplasm,Pineal Region Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397982Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma · 175 trials list this drug (10 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00808899Phase 2 · terminated Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma · 175 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222715Phase 2 · completed Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma · 175 trials list this drug (10 active) | — | — | Adult Soft Tissue Sarcoma,Adult Rhabdomyosarcoma,Childhood Rhabdomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · 175 trials list this drug (10 active) | — | — | Salivary Gland Carcinoma,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00703625Phase 1 · completed Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01264341Phase 2 · terminated Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093782Phase 2 · completed Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma · 175 trials list this drug (10 active) | — | — | Digestive System Neuroendocrine Tumor G1,Lung Neuroendocrine Tumor,Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204450Phase 1 · terminated Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma · 175 trials list this drug (10 active) | — | — | Childhood Solid Neoplasm,Sarcoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00921310Phase 1/Phase 2 · terminated Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer · 175 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061606Phase 2 · terminated Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus · 175 trials list this drug (10 active) | — | — | Uterine Corpus Sarcoma,Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251458Phase 1/Phase 2 · completed Hepatocellular Carcinoma (HCC)_Torisel_ · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00877773Phase 1/Phase 2 · terminated Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404104NA · completed Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155258Phase 1 · completed Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors · 175 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Ovarian Germ Cell Tumor,Cutaneous Merkel Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01535989Phase 1 · completed Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01183663Phase 1 · completed Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00631371Phase 3 · completed Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460979Phase 2 · completed Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma · 175 trials list this drug (10 active) | — | — | Ovarian Neoplasm,Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01206036Phase 1/Phase 2 · completed CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) · 175 trials list this drug (10 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00693433Phase 1 · completed Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma · 175 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01122615Phase 1 · completed Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) · 175 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01902160Phase 1 · completed Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · 175 trials list this drug (10 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678769Phase 1 · completed Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625156Phase 1 · completed Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548482Phase 1 · completed Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm,Digestive System Neuroendocrine Tumor G1,Lung Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01206140Phase 2 · completed Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery · 175 trials list this drug (10 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026792Phase 2 · completed Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery · 175 trials list this drug (10 active) | — | — | Cervical Adenocarcinoma,Cervical Squamous Cell Carcinoma,Cervical Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01009203Phase 2 · terminated Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01016015Phase 2 · completed Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma · 175 trials list this drug (10 active) | — | — | Osteosarcoma,Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01403415Phase 1 · completed Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma · 175 trials list this drug (10 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia,Childhood Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112736Phase 1/Phase 2 · completed Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma · 175 trials list this drug (10 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022464Phase 2 · completed CCI-779 in Treating Patients With Metastatic Melanoma · 175 trials list this drug (10 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00770263Phase 1 · completed Erlotinib and Temsirolimus for Solid Tumors · 175 trials list this drug (10 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446431early Phase 1 · recruiting Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence · 175 trials list this drug (10 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255658Phase 1 · completed Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01851408Phase 2 · withdrawn Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma · 175 trials list this drug (10 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529138Phase 1 · completed Study of Axitinib and Temsirolimus in Solid Tumors · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117598Phase 3 · completed Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) · 175 trials list this drug (10 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788580Phase 1 · withdrawn S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072176Phase 2 · completed Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer · 175 trials list this drug (10 active) | — | — | Endometrial Adenocarcinoma,Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01020305Phase 1/Phase 2 · terminated Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer · 175 trials list this drug (10 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919035Phase 2 · completed Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients · 175 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01417065early Phase 1 · completed Temsirolimus In Phase 0 · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408655Phase 1 · completed Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm,Ovarian Germ Cell Tumor,Malignant Ovarian Epithelial Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01198184Phase 1 · completed Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm,Endometrial Carcinoma,Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290472Phase 2 · completed CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm,Non-Hodgkin Lymphoma,Adult Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281957Phase 2 · completed Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery · 175 trials list this drug (10 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01166126Phase 2 · terminated Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV · 175 trials list this drug (10 active) | — | — | Melanoma,Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880282Phase 1 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment · 175 trials list this drug (10 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00109967Phase 2 · completed CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · 175 trials list this drug (10 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00349206Phase 1 · completed Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma · 175 trials list this drug (10 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141244Phase 1 · completed Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors · 175 trials list this drug (10 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033267Phase 2 · completed CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma · 175 trials list this drug (10 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01079767Phase 2 · terminated Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis · 175 trials list this drug (10 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887640Phase 2 · terminated Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer · 175 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00474786Phase 3 · completed Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00949026Phase 1 · withdrawn Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis · 175 trials list this drug (10 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00483262Phase 1/Phase 2 · completed Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma · 175 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01172769Phase 2 · completed Efficacy Study of Temsirolimus to Treat Head and Neck Cancer · 175 trials list this drug (10 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079456Phase 2 · completed Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma · 175 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00398515Phase 1 · completed Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma · 175 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016328Phase 2 · completed CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme · 175 trials list this drug (10 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079235Phase 2 · completed CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer · 175 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796796Phase 1 · completed Temsirolimus and Radiation for Non-Small Cell Lung Cancer · 175 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012142Phase 2 · completed CCI-779 in Treating Patients With Prostate Cancer · 175 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045370Phase 1 · completed Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · 175 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087074Phase 2 · completed CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor · 175 trials list this drug (10 active) | — | — | Gastrointestinal Stromal Tumor,Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098501Phase 1 · completed CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659568Phase 1 · completed Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm,Lymphoma,Malignant Breast Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00703170Phase 1 · completed Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112476Phase 1 · completed Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm,Melanoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01781442withdrawn A Post Marketing Surveillance As Required By Philippine Food And Drug Administration · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942747Phase 2 · unknown Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00316849Phase 1 · completed Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 175 trials list this drug (10 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494091Phase 2 · completed Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028028Phase 2 · completed CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 175 trials list this drug (10 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00619268Phase 2 · completed Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00770731Phase 1 · completed Study of Temsirolimus, Topotecan, and Bortezomib · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00106353Phase 1/Phase 2 · completed Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors · 175 trials list this drug (10 active) | — | — | Neoplasm,Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00275093Phase 1 · completed Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function · 175 trials list this drug (10 active) | — | — | Adult Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086840Phase 2 · terminated CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia · 175 trials list this drug (10 active) | — | — | Adult Hodgkin Lymphoma,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084916Phase 2 · completed CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase · 175 trials list this drug (10 active) | — | — | Myelodysplastic Syndrome,Adult Acute Lymphoblastic Leukemia,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075647Phase 2 · completed CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 175 trials list this drug (10 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101088Phase 1 · terminated Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia · 175 trials list this drug (10 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071968Phase 2 · completed Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse · 175 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512668Phase 1 · terminated Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer · 175 trials list this drug (10 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01015664Phase 1/Phase 2 · terminated Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · 175 trials list this drug (10 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567930Phase 2 · unknown Temsirolimus as Second-line Therapy in HCC · 175 trials list this drug (10 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00065468Phase 3 · completed Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma · 175 trials list this drug (10 active) | — | — | Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003712Phase 1 · completed CCI-779 in Treating Patients With Advanced Solid Tumors · 175 trials list this drug (10 active) | — | — | Malignant Neoplasm,Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979966Phase 2 · completed Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib · 175 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01246817Phase 2 · unknown Temsirolimus-RCC-imaging · 175 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00593008Phase 1 · terminated Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer · 175 trials list this drug (10 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00926107Phase 2 · terminated Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse · 175 trials list this drug (10 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00827684Phase 2 · completed Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations · 175 trials list this drug (10 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01170052Phase 1/Phase 2 · withdrawn Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL) · 175 trials list this drug (10 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00800917Phase 2 · completed A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme · 175 trials list this drug (10 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00195299completed Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck · 175 trials list this drug (10 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00235794NA · completed An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients · 175 trials list this drug (10 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |